Vulnerability found in viral replication opens new doors to antiviral drug research
By Cate Wilkinson | Feb. 8, 2018Masaki Nishikiori, a researcher in the Morgridge Institute for Research Virology Team led by Paul Ahlquist, and his research specialist Zach Coleman have made an unprecedented discovery that could lead to the creation of a general antiviral drug for a specific class of (+) RNA viruses.
















